Indonesia investment authority, China Silk Road Fund subscribe to Kimia Farma’s convertible…
The investment aims to accelerate access to healthcare across Indonesia, INA CEO Ridha Wirakusumah said in a statement.
Both INA, which is Indonesia's sovereign wealth fund, and SRF have also acquired 40% shares of Kimia…